Renal Cancer - Results from #2360

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program. December 2, 2020

Gene Expression and Co-expression Networks Are Strongly Altered Through Stages in Clear Cell Renal Carcinoma. December 1, 2020

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis. December 1, 2020

Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma. December 1, 2020

Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis. November 30, 2020

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial. November 30, 2020

A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. November 30, 2020

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan. November 27, 2020

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma. November 27, 2020

A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. November 27, 2020

Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. November 26, 2020

Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study. November 26, 2020

An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study. November 26, 2020

Identification of an independent autophagy-gene prognostic index for papillary renal cell carcinoma. November 26, 2020

Urinary collecting system invasion on multiphasic CT in renal cell carcinomas: prevalence, characteristics, and clinical significance. November 25, 2020

Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma. November 25, 2020

Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma. November 25, 2020

Improving segmentation accuracy of CT kidney cancer images using adaptive active contour model. November 24, 2020

Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma. November 24, 2020

Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. November 24, 2020

Page 119 of 457